Investigation on the effect of favipiravir in preventing Ebola virus disease and its safety
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Favipiravir (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
- 15 Nov 2017 Status changed from recruiting to completed.
- 03 Aug 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 06 Jan 2015 New trial record